210 related articles for article (PubMed ID: 22110528)
1. ELISA-based measurement of antibody responses and PCR-based detection profiles can distinguish between active infection and early clearance of Borrelia burgdorferi.
Lazarus JJ; McCarter AL; Neifer-Sadhwani K; Wooten RM
Clin Dev Immunol; 2012; 2012():138069. PubMed ID: 22110528
[TBL] [Abstract][Full Text] [Related]
2. Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.
Jobe DA; Lovrich SD; Asp KE; Mathiason MA; Albrecht SE; Schell RF; Callister SM
Clin Vaccine Immunol; 2008 Jun; 15(6):981-5. PubMed ID: 18417666
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-linked immunosorbent assay, immunofluorescent assay, and recombinant immunoblotting in the serodiagnosis of early Lyme borreliosis.
Christova I
Int J Immunopathol Pharmacol; 2003; 16(3):261-8. PubMed ID: 14611730
[TBL] [Abstract][Full Text] [Related]
5. Immune responses to borrelial VlsE IR6 peptide variants.
Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
[TBL] [Abstract][Full Text] [Related]
6. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
Dickeson DJ; Chen SC; Sintchenko VG
Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
[TBL] [Abstract][Full Text] [Related]
7. The Classical Complement Pathway Is Required to Control
Zhi H; Xie J; Skare JT
Front Immunol; 2018; 9():959. PubMed ID: 29867944
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
[TBL] [Abstract][Full Text] [Related]
9. Tick-Tattoo: DNA Vaccination Against
Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
Front Immunol; 2021; 12():615011. PubMed ID: 33717102
[TBL] [Abstract][Full Text] [Related]
10. Experimental infection of laboratory mice and rabbits with several isolates of Borrelia burgdorferi sensu lato; comparison of antigens from different genospecies in serological measurement of immune responses.
Tuomi J; Rantamaki LK; Tanskanen R
Comp Immunol Microbiol Infect Dis; 2002 Mar; 25(2):109-25. PubMed ID: 11848128
[TBL] [Abstract][Full Text] [Related]
11. No Value for Routine Serologic Screening for Borrelia burgdorferi in Patients With Uveitis in the Netherlands.
Kazi H; de Groot-Mijnes JDF; Ten Dam-van Loon NH; Ossewaarde-van Norel J; Oosterheert JJ; de Boer JH
Am J Ophthalmol; 2016 Jun; 166():189-193. PubMed ID: 27080573
[TBL] [Abstract][Full Text] [Related]
12. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
Bradshaw GL; Thueson RK; Uriona TJ
J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
[TBL] [Abstract][Full Text] [Related]
13. Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment.
Yrjänäinen H; Hytönen J; Hartiala P; Oksi J; Viljanen MK
APMIS; 2010 Sep; 118(9):665-73. PubMed ID: 20718718
[TBL] [Abstract][Full Text] [Related]
14. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
Wagner B; Freer H; Rollins A; Erb HN
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
[TBL] [Abstract][Full Text] [Related]
15. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis.
Chmielewska-Badora J; Cisak E; Wójcik-Fatla A; Zwoliński J; Buczek A; Dutkiewicz J
Ann Agric Environ Med; 2006; 13(2):307-11. PubMed ID: 17196006
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of serologic tests for lyme disease.
Steere AC; McHugh G; Damle N; Sikand VK
Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
[TBL] [Abstract][Full Text] [Related]
17. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis.
Magnarelli LA; Lawrenz M; Norris SJ; Fikrig E
J Med Microbiol; 2002 Aug; 51(8):649-655. PubMed ID: 12171295
[TBL] [Abstract][Full Text] [Related]
18. Enhanced detection of host response antibodies to Borrelia burgdorferi using immuno-PCR.
Halpern MD; Jain S; Jewett MW
Clin Vaccine Immunol; 2013 Mar; 20(3):350-7. PubMed ID: 23302740
[TBL] [Abstract][Full Text] [Related]
19. Application of multiplexing technology to the analysis of the intrathecally released immunoglobulins against B. burgdorferi antigens in neuroborreliosis.
Zajkowska J; Lelental N; Kulakowska A; Mroczko B; Pancewicz S; Bucki R; Kornhuber J; Lewczuk P
Immunol Lett; 2015 Nov; 168(1):58-63. PubMed ID: 26210581
[TBL] [Abstract][Full Text] [Related]
20. Laboratory testing for suspected Lyme disease.
Bunikis J; Barbour AG
Med Clin North Am; 2002 Mar; 86(2):311-40. PubMed ID: 11982304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
